PELOTON THERAPEUTICS
Dead · Refused DEAD/APPLICATION/Refused/Dismissed or Invalidated
What this record means
The record shows that “PELOTON THERAPEUTICS” is a dead, abandoned mark owned by Peloton Therapeutics, Inc., a Delaware corporation, that was filed on December 11, 2018 and abandoned on February 14, 2022 because no Statement of Use or Extension Request was filed after the Notice of Allowance. The mark was registered on the Principal Register for classes 005 (pharmaceutical preparations for treating various diseases, including cancer, inflammation, metabolic disorders, pulmonary hypertension, and inflammatory bowel disease) and 042 (pharmaceutical research and development services). A similar name would raise the closest concern in the pharmaceutical and research services areas, especially where the goods or services overlap with those listed. The record does not give the owner control over every use of the wording, and no enforcement activity such as oppositions or cancellations appears in the supplied history. The latest event is the abandonment notice in February 2022. For someone considering a similar name, the abandoned status reduces the risk of direct conflict, but the specific pharmaceutical scope still represents a potential concern if the new use is in the same or related fields.
Informational only - not legal advice.Mark Trademark, Service Mark
| Drawing type | 4 - STANDARD CHARACTER MARK |
| Filing basis | Intent-to-Use (§1(b)). |
| Status | Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Key dates
| Application filed | Dec 11, 2018 |
| Published for opposition | May 14, 2019 |
| Notice of Allowance | Jul 09, 2019 |
| Status date | Feb 14, 2022 |
Goods & services
Pharmaceutical preparations for the treatment of cancerous diseases, inflammation, metabolic diseases, pulmonary hypertension and inflammatory bowel disease; Pharmaceutical preparations for use in the field of oncology; pharmaceutical preparations, namely, medicines for human consumption taken orally for treatment of cancerous diseases, inflammation, metabolic diseases, pulmonary hypertension, inflammatory diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-inflammatories, anti-virals, anti-infectives, immunosuppressants and pharmaceutical antibodies
Pharmaceutical research and development services for research and development of human pharmaceutical preparations
Owner & representation
| Owner | Peloton Therapeutics, Inc. |
| Address | 2330 Inwood Road, Suite 226, Dallas, TEXAS UNITED STATES 752357323 |
| Entity | CORPORATION - organized in DELAWARE |
| Attorney of record | Lisa M. Dellamura |
| Correspondent | Lisa M. Dellamura |
| Attorney email | l********@*****.com |
| Correspondent email | 3 emails |
| Correspondent phone | 7********2 |
| Correspondent address | RAHWAY, NEW |